Efficacy and safety of widely used treatments for macular oedema secondary to retinal vein occlusion: a systematic review
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2415
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Efficacy and safety of widely used treatments for macular oedema secondary to retinal vein occlusion: a systematic review ; volume:14 ; number:1 ; day:21 ; month:1 ; year:2014 ; pages:1-15 ; date:12.2014
BMC ophthalmology ; 14, Heft 1 (21.1.2014), 1-15, 12.2014
- Urheber
-
Glanville, Julie
- Beteiligte Personen und Organisationen
-
Patterson, Jacoby
McCool, Rachael
Ferreira, Alberto
Gairy, Kerry
Pearce, Ian
SpringerLink (Online service)
- DOI
-
10.1186/1471-2415-14-7
- URN
-
urn:nbn:de:1111-201604148512
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:51 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Glanville, Julie
- Patterson, Jacoby
- McCool, Rachael
- Ferreira, Alberto
- Gairy, Kerry
- Pearce, Ian
- SpringerLink (Online service)
Ähnliche Objekte (12)
Indirect comparisons of ranibizumab and dexamethasone in macular oedema secondary to retinal vein occlusion
Anti-vascular endothelial growth factor dosing frequency and visual outcomes in macular oedema following branch retinal vein occlusion
Intravitreal dexamethasone implant versus triamcinolone acetonide for macular oedema of central retinal vein occlusion: quantifying efficacy and safety
Real-World Results of Switching Treatment from Ranibizumab to Aflibercept in Macular Oedema Secondary to Branch Retinal Vein Occlusion
Real-world outcomes of intravitreal bevacizumab treat-and-extend for cystoid macular oedema secondary to central retinal vein occlusion
Characteristics of major and macular branch retinal vein occlusion
Treatment of Branch Retinal Vein Occlusion induced Macular Edema with Bevacizumab
Intravitreal dexamethasone implant for central retinal vein occlusion without macular edema
Cost Effectiveness of Ranibizumab vs Aflibercept vs Bevacizumab for the Treatment of Macular Oedema Due to Central Retinal Vein Occlusion: The LEAVO Study
A treat and extend protocol with Aflibercept for cystoid macular oedema secondary to central retinal vein occlusion – an 18-month prospective cohort study
Correlation between macular edema recurrence and macular capillary network destruction in branch retinal vein occlusion
Interpretation of SD-OCT imaging data in real-life conditions versus standardized reading centre analysis in eyes with diabetic macular oedema or macular oedema secondary to retinal vein occlusion: 24-month follow-up of the ORCA study
Indirect comparisons of ranibizumab and dexamethasone in macular oedema secondary to retinal vein occlusion
Anti-vascular endothelial growth factor dosing frequency and visual outcomes in macular oedema following branch retinal vein occlusion
Intravitreal dexamethasone implant versus triamcinolone acetonide for macular oedema of central retinal vein occlusion: quantifying efficacy and safety
Real-World Results of Switching Treatment from Ranibizumab to Aflibercept in Macular Oedema Secondary to Branch Retinal Vein Occlusion
Real-world outcomes of intravitreal bevacizumab treat-and-extend for cystoid macular oedema secondary to central retinal vein occlusion
Characteristics of major and macular branch retinal vein occlusion
Treatment of Branch Retinal Vein Occlusion induced Macular Edema with Bevacizumab
Intravitreal dexamethasone implant for central retinal vein occlusion without macular edema
Cost Effectiveness of Ranibizumab vs Aflibercept vs Bevacizumab for the Treatment of Macular Oedema Due to Central Retinal Vein Occlusion: The LEAVO Study
A treat and extend protocol with Aflibercept for cystoid macular oedema secondary to central retinal vein occlusion – an 18-month prospective cohort study
Correlation between macular edema recurrence and macular capillary network destruction in branch retinal vein occlusion
Interpretation of SD-OCT imaging data in real-life conditions versus standardized reading centre analysis in eyes with diabetic macular oedema or macular oedema secondary to retinal vein occlusion: 24-month follow-up of the ORCA study
Indirect comparisons of ranibizumab and dexamethasone in macular oedema secondary to retinal vein occlusion
Anti-vascular endothelial growth factor dosing frequency and visual outcomes in macular oedema following branch retinal vein occlusion
Intravitreal dexamethasone implant versus triamcinolone acetonide for macular oedema of central retinal vein occlusion: quantifying efficacy and safety
Real-World Results of Switching Treatment from Ranibizumab to Aflibercept in Macular Oedema Secondary to Branch Retinal Vein Occlusion
Real-world outcomes of intravitreal bevacizumab treat-and-extend for cystoid macular oedema secondary to central retinal vein occlusion
Characteristics of major and macular branch retinal vein occlusion
Treatment of Branch Retinal Vein Occlusion induced Macular Edema with Bevacizumab
Intravitreal dexamethasone implant for central retinal vein occlusion without macular edema
Cost Effectiveness of Ranibizumab vs Aflibercept vs Bevacizumab for the Treatment of Macular Oedema Due to Central Retinal Vein Occlusion: The LEAVO Study
A treat and extend protocol with Aflibercept for cystoid macular oedema secondary to central retinal vein occlusion – an 18-month prospective cohort study
Correlation between macular edema recurrence and macular capillary network destruction in branch retinal vein occlusion